文献速递前列腺癌

晚期前列腺癌患者循环雌激素受体突变与剪接变异体的特征分析

Circulating oestrogen receptor mutations and splice variants in advanced prostate cancer.
PubMed 文献 · BJU Int · 2019-10-03

研究对42例晚期前列腺癌患者及健康对照的系列血样行微滴数字PCR,检测6种ERα突变及6种ERα/ERβ剪接变异体,在患者样本中检出4种突变和全部6种剪接变异体,ER突变与骨转移及去势抵抗相关,ERβ剪接变异体浓度随治疗线数增加而下降。

要点

  • 在晚期前列腺癌患者血浆中可检出ERα突变(E380Q、L536Q、Y537S、D538G)。
  • ER突变的存在与骨转移和去势抵抗相关。
  • ERβ剪接变异体浓度在连续多线治疗后下降。

核心结论

  • 晚期前列腺癌患者血浆中可检测到ER突变。
  • ER剪接变异体在前列腺癌患者和无前列腺癌男性中均频繁检出。

研究设计与样本

  • 研究纳入晚期前列腺癌男性及健康对照,采集系列血样。
  • 采用微滴数字PCR检测血源性RNA样本中6种ERα突变和6种ERα/ERβ剪接变异体。
  • 共从42例晚期前列腺癌男性中收集94份样本。

主要发现

  • 在患者样本中检出4种突变(E380Q、L536Q、Y537S、D538G)和全部6种剪接变异体。
  • 非癌症对照样本中也可检出剪接变异体。
  • ER突变的存在与骨转移和去势抵抗相关。
  • ERβ剪接变异体浓度在连续多线治疗后下降。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize circulating oestrogen receptor ( ER) mutants and splice variants in men with advanced prostate cancer. MATERIALS AND METHODS: Sequential blood samples were obtained from men with advanced prostate cancer, and from healthy controls. Blood-derived RNA samples were analysed using droplet digital PCR for the presence of six ERα mutations (E380Q, L536Q, Y537C, Y537S, Y537N and D538G), and six ERα and ERβ splice variants (ERα-66, ERα-36, ERβ1, ERβ2, ERβ4 & ERβ5). RESULTS: A total of 94 samples were collected from 42 men with advanced prostate cancer. Four mutations (E380Q, L536Q, Y537S and D538G) and all six splice variants were detected in patient samples. Splice variants were detectable in non-cancer control samples. The presence of ER mutations was associated with bone metastases and castration resistance. ERβ splice variant concentrations decreased after successive lines of treatment. CONCLUSIONS: The ER mutations were detectable in plasma from patients with advanced prostate cancer. ER splice variants were frequently detected in both men with and without prostate cancer.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Qu LG, Wardan H, Davis ID, et al. Circulating oestrogen receptor mutations and splice variants in advanced prostate cancer. BJU Int. 2019. PMID: 31090242. doi:10.1111/bju.14797

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。